Regulus Therapeutics Newsroom

Oppenheimer Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 12 21:31

H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 11 20:31

Regulus Therapeutics Analyst Ratings

BenzingaNov 11 20:27

Regulus Therapeutics Poised for Growth: Promising ADPKD Study Results and Strategic Milestones Drive Buy Rating

TipRanksNov 11 19:40

Buy Rating for Regulus Therapeutics Driven by Promising Clinical and Regulatory Prospects for RGLS8429

TipRanksNov 11 14:31

H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 30 19:31

H.C. Wainwright Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 8 22:31

Regulus Therapeutics Analyst Ratings

BenzingaAug 15 01:37

Oppenheimer Reiterates Outperform on Regulus Therapeutics, Maintains $7 Price Target

BenzingaAug 15 01:37

Oppenheimer Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $7

Futu NewsAug 14 20:31

Regulus Therapeutics Analyst Ratings

BenzingaAug 10 05:27

HC Wainwright & Co. Reiterates Buy on Regulus Therapeutics, Maintains $10 Price Target

BenzingaAug 10 05:27

Buy Rating Reaffirmed for Regulus Therapeutics Amidst Promising Clinical Data and Progress Towards Pivotal Trial

TipRanksAug 9 20:16

Oppenheimer Maintains Regulus Therapeutics(RGLS.US) With Buy Rating, Maintains Target Price $7

Futu NewsAug 2 20:36

Oppenheimer Initiates Regulus Therapeutics at Outperform With $7 Price Target

MT NewswiresAug 2 19:39

Oppenheimer Initiates Regulus Therapeutics(RGLS.US) With Buy Rating, Announces Target Price $7

Futu NewsAug 2 05:32

Regulus Therapeutics Analyst Ratings

BenzingaJul 16 20:14

HC Wainwright & Co. Reiterates Buy on Regulus Therapeutics, Maintains $10 Price Target

BenzingaJul 16 20:13

Buy Rating Affirmed for Regulus Therapeutics Amid Positive RGLS8429 Study Results

TipRanksJul 16 18:27

HC Wainwright & Co. Maintains Buy on Regulus Therapeutics, Raises Price Target to $10

BenzingaJun 25 18:50